Equities Analysts Issue Forecasts for Biogen FY2025 Earnings
Equities research analysts at Cantor Fitzgerald decreased their FY2025 earnings estimates for Biogen in a research note ...
Cantor Fitzgerald Reaffirms Overweight Rating for Aurora Innovation (NASDAQ:AUR)
Aurora Innovation (NASDAQ:AUR – Get Free Report)‘s stock had its “overweight” rating reiterated by equities researchers at ...
El País in English11h
Wrestling, cannabis, bitcoin and stocks: This is how Trump’s government of billionaires invests
Although Elon Musk attracts most of the headlines, the US Cabinet is full of other wealthy individuals who have significant ...
Cantor Fitzgerald maintains $118 target on Ultragenyx stock
Cantor Fitzgerald reaffirmed its Overweight rating and $118.00 price target for Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), a biopharmaceutical company specializing in rare diseases. Currently ...